当行人过道成为危险区时:老年行人创伤和死亡风险
Peter Pavol1, Vasileios Topalis1, Sofia-Chrysovalantou Zagalioti2
1Department of Emergency Medicine, Inselspital University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
International journal of environmental research and public health
|October 29, 2025
概括
与年轻人相比,65岁以上的老行人经历了更严重的伤害和更高的死亡率. 这凸显了针对老年人口制定有针对性的安全策略和优化医疗护理的需要.
科学领域:
- 创伤学 创伤学 创伤学
- 老年医学 老年医学
- 公共卫生 公共卫生
背景情况:
- 年长的成年行人面临严重伤害的高风险,原因是与年龄相关的身体衰退和先前存在的医疗条件.
- 这些风险转化为长时间住院,增加死亡率和老龄化人口的医疗保健成本.
- 步行者交叉路口事故对老年人的福祉构成重大威胁.
研究的目的:
- 研究涉及瑞士伯尔尼老年人的行人交叉路口事故的特征和受伤模式.
- 将老年行人 (65岁以上) 的临床结果与年轻行人 (65岁以下) 的临床结果进行比较.
主要方法:
- 一项回顾性队列研究分析了在2013年至2023年期间因行人交叉路口事故而被送往急诊室 (ED) 的成年患者.
- 患者被分为两组:65岁以下和65岁以上.
- 收集的数据包括事故的场景,伤害类型,伤害模式以及临床结果,如ICU和医院的死亡率和停留时间 (LOS).
主要成果:
- 高龄行人 (65岁以上) 占研究人群的31.5%,更有可能作为住院患者和进入ICU.
- 老年人患有更多的多创伤,包括上肢,骨盆和胸脊骨折,以及更高的内出血率,腹部创伤和血管损伤.
- 65岁以上的群体在医院和ICU住院时间明显长,住院时间超过7天的发生率更高,住院和30天死亡率明显更高.
结论:
- 步行者十字路口事故对老年人产生更严重的影响,受伤严重程度增加,住院率增加,停留时间延长和死亡率增加.
- 调查结果强调,需要制定具体策略,以减轻行人交叉路口事故,并加强对这一弱势群体的患者管理.
相关概念视频
01:15Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
01:19The Effect of Aging on Tissues
3.2K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.2K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232